MedTrace Logo

Sugammadex Administration in Pregnancy

NCT05708469 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2024-05-08

No results posted yet for this study

Summary

In this study, the investigators aimed to evaluate the maternal and fetal effect of sugammadex in pregnant patients undergoing a non-obstetric surgery. The investigators mainly focused on the short- and long-term adverse effects such as an abortion or a teratogenic effect and that may occur in fetus and the adverse effects that may be seen in mother.

Conditions

  • Sugammadex, Pregnant, Anesthesia

Sponsors & Collaborators

  • Sakarya University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-15
Primary Completion
2023-06-15
Completion
2023-08-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05708469 on ClinicalTrials.gov